NCT06363942 A Personalized Video-based Exercise Program for Fall Prevention in Frail and Pre-frail Older Adult
| NCT ID | NCT06363942 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Condition | Fall Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-07-01 with a primary completion date of 2026-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized interventional clinical trial, whereby 100 participants will be randomized to either follow the SAFE exercise program (experimental group) or not (control group). At the end of the intervention, the experimental group will be encouraged to continue doing the exercises, and the control group will have the opportunity to participate in the SAFE exercises. 12 weeks post-intervention, the investigators will follow up with participants by telephone to follow up whether they are still following the SAFE program or not.
Eligibility Criteria
Inclusion Criteria: * Considered Frail or Pre frail according to Fried's criteria Exclusion Criteria: * Smoked within 6 months prior to study enrollment, * dementia diagnosos, * Abused drugs, medication or alcohol within up to 30 days prior to the start of the study. * drug or alcohol-addiction, * Heart disease, history of heart attacks or electrocardiogram abnormalities * Any family history of thrombosis, thrombosis risk, * hypocalcaemia, * uric acidemia, * orthostatic intolerance, * vestibular disorders, * considerable musculoskeletal issues, * chronic back pain, * head trauma, * seizures, * ulcers, * renal stones, * gastro-esophageal reflux disease, * renal function disorder, * hiatus hernia, * migraines, * mental illness diagnosis * prescribed medication that may interfere with the interpretation of the results
Contact & Investigator
Jose Morais, MD
PRINCIPAL INVESTIGATOR
McGill University Health Centre/Research Institute of the McGill University Health Centre
Frequently Asked Questions
Who can join the NCT06363942 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Fall Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06363942 currently recruiting?
Yes, NCT06363942 is actively recruiting participants. Contact the research team at guyelhajj@gmail.com for enrollment information.
Where is the NCT06363942 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06363942 clinical trial?
NCT06363942 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The principal investigator is Jose Morais, MD at McGill University Health Centre/Research Institute of the McGill University Health Centre. The trial plans to enroll 100 participants.